Trial NCT04083898

View at ClinicalTrials.gov 
Org. Study IDs: 201910194

Last trial update was posted on 2024-03-19

MeSH Interventions

Bendamustine Hydrochloride Prednisone

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Decision made to not move forward with Phase II portion of trial

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID